Boxes of Dengvaxia dengue vaccine lie in storage in biological refrigerators at the Philippine Children’s Medical Center (PCMC). INQUIRER PHOTO / LYN RILLON
Officials involved in the possible overpricing of the now-controversial vaccine, Dengvaxia, should be held liable, Sen. Grace Poe said Thursday.
During the House committee on good government and public accountability hearing on the botched immunization program on Wednesday, found that the government bought the vaccine for $21 “societal price” instead of its $13 threshold price.
“Aba, dapat talaga matukoy kung sino naging responsable, bakit natin ginawa yon?” Poe said in an interview during the commemoration of the 13th death anniversary of her father, Fernando Poe Jr., at the Manila North Cemetery.
(We should know who was responsible, why did we do that?)
“We shouldn’t allow the government to be at the losing side of the bargain, of a deal. Malaking kasalanan ‘yan. So sino nagdesisyon? (It’s a big mistake. Who decided on the deal?)
Lawmakers also found during the Wednesday hearing that a member of the Department of Health (DOH)’s Formulary Executive Committee (FEC), Dr. Hilton Lam, was commissioned by Sanofi Pasteur to study the cost effectiveness of Dengvaxia.
Lam said that the study set the pricing of the vaccine’s threshold price at $13 (P600), and “societal price” at $21 (P1,000) per dose. He said the latter amount included “productivity losses” or the accounting of one’s future income if he dies or the loss of income if someone’s parents die.
Lam admitted that he was paid by Sanofi Pasteur P300,000 for the study.
This did not sit well with the lawmakers, who said it was inappropriate for him to undertake the study being a member of the FEC, the DOH body that approves the medicines to be included in the National Formulary, or the list of drugs the government can buy and use. /cbb